Related Experiment Video
Updated: May 23, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis
Jan H Rüschoff1, Timo Brandenburger, Emanuel E Strehler
1Department of Anatomy and Cell Biology, Philipps-University, Marburg, Germany.
Cancer Investigation
|April 7, 2012
Summary
Plasma membrane Ca(2+) ATPase (PMCA4) protein is reduced in colon cancer and metastasis, but RNA levels remain stable. This suggests post-transcriptional regulation of PMCA4 impacts colon cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Plasma membrane Ca(2+) ATPase (PMCA) proteins regulate intracellular calcium levels.
- Dysregulation of calcium homeostasis is implicated in cancer development.
- PMCA4's role in colon carcinogenesis is not fully understood.
Purpose of the Study:
- To investigate the expression and regulation of PMCA4 in normal colon mucosa, adenoma, adenocarcinoma, and lymph node metastasis.
- To determine if PMCA4 expression changes correlate with colon cancer progression.
Main Methods:
- Analysis of 84 colon tissue samples (normal, adenoma, adenocarcinoma, metastasis) using immunohistochemistry, mRNA in situ hybridization, and quantitative reverse-transcriptase PCR.
- Quantification of PMCA4 protein and RNA levels.
Main Results:
- A significant reduction in PMCA4 protein expression was observed in high-grade adenomas, colon cancer, and lymph node metastases.
- PMCA4 RNA transcripts showed no significant change or an increase in colon carcinomas compared to normal mucosa.
- Discrepancy between protein and RNA levels suggests post-transcriptional regulation.
Conclusions:
- PMCA4 protein downregulation is associated with colon cancer progression and metastasis.
- Post-transcriptional mechanisms likely regulate PMCA4 expression during colon carcinogenesis.
- PMCA4 may serve as a potential biomarker or therapeutic target in colon cancer.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:22Enlargement of the Plasma Membrane
Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
01:27Feedback Regulation of Calcium Concentration
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:34ATP Driven Pumps II: P-type Pumps
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...